Exchange: NASDAQ·Updated 03:09 PM EDT

BPTS Biophytis SA ADR

$0.25
$0.00
(0.00%)
Today
Mkt Cap$4.34M
Vol14.00

About BPTS

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
0

Extremely Bearish Sentiment

How do you feel about BPTS?

Advertisement|Remove ads.